| Gout, Hyperuricemia, Uric Acid | Lifetime | 28 | TR 1 | 98.89 |
| Dialysis and Renal Disease Management | Lifetime | 194 | TR 1 | 98.93 |
| Parathyroid Disorders and Treatments | Lifetime | 278 | TR 1 | 98.11 |
| Chronic Kidney Disease and Diabetes | Lifetime | 315 | TR 1 | 98.23 |
| Muscle and Compartmental Disorders | Lifetime | 143 | TR 2 | 96.93 |
| Alcohol Consumption and Health Effects | Lifetime | 461 | TR 1 | 96.80 |
| Blood Pressure and Hypertension Studies | Lifetime | 965 | TR 1 | 97.46 |
| Case Reports on Hematomas | Lifetime | 72 | TR 1 | 95.48 |
| Acute Kidney Injury Research | Lifetime | 474 | TR 1 | 95.57 |
| Inflammasome and immune disorders | Lifetime | 776 | TR 29 | 93.93 |
| Sodium Intake and Health | Lifetime | 437 | TR 1 | 93.93 |
| Erythropoietin and Anemia Treatment | Lifetime | 761 | TR 4 | 90.50 |
| Potassium and Related Disorders | Lifetime | 576 | TR 2 | 90.25 |
| Magnesium in Health and Disease | Lifetime | 474 | TR 2 | 89.89 |
| Biomedical Research and Pathophysiology | Lifetime | 596 | TR 4 | 88.89 |
| Biomarkers in Disease Mechanisms | Lifetime | 834 | TR 9 | 80.90 |
| Dialysis and Renal Disease Management | 2021-2025 | 31 | TR 1 | 99.04 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 52 | TR 1 | 98.62 |
| Muscle and Compartmental Disorders | 2021-2025 | 11 | TR 1 | 96.93 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 592 | TR 2 | 97.39 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 46 | TR 1 | 94.18 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 236 | TR 1 | 96.03 |
| Diabetes Treatment and Management | 2021-2025 | 289 | TR 2 | 96.84 |
| Biomedical Research and Pathophysiology | 2021-2025 | 17 | TR 2 | 94.90 |
| Renal Transplantation Outcomes and Treatments | 2021-2025 | 232 | TR 3 | 95.48 |
| Diet and metabolism studies | 2021-2025 | 694 | TR 3 | 94.04 |
| Parathyroid Disorders and Treatments | 2021-2025 | 158 | TR 1 | 94.48 |
| Renal Diseases and Glomerulopathies | 2021-2025 | 271 | TR 1 | 94.96 |
| Pancreatic function and diabetes | 2021-2025 | 426 | TR 2 | 93.03 |
| Hormonal Regulation and Hypertension | 2021-2025 | 251 | TR 1 | 91.48 |
| Diet, Metabolism, and Disease | 2021-2025 | 346 | TR 3 | 91.36 |
| Renal and Vascular Pathologies | 2021-2025 | 267 | TR 1 | 88.93 |
| Nutritional Studies and Diet | 2021-2025 | 963 | TR 2 | 90.79 |
| Acute Kidney Injury Research | 2021-2025 | 304 | TR 1 | 89.30 |
| Ion Transport and Channel Regulation | 2021-2025 | 87 | TR 1 | 88.03 |
| Sodium Intake and Health | 2021-2025 | 233 | TR 1 | 83.19 |
| Genetic Syndromes and Imprinting | 2021-2025 | 293 | TR 2 | 78.33 |
| Electrolyte and hormonal disorders | 2021-2025 | 288 | TR 1 | 80.50 |
| Genetic and Kidney Cyst Diseases | 2021-2025 | 595 | TR 6 | 72.25 |
| Case Reports on Hematomas | 2021-2025 | 98 | TR 1 | 73.18 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 811 | TR 2 | 54.26 |
| Neurological Complications and Syndromes | 2021-2025 | 774 | TR 5 | 53.12 |